• isi_ọkọlọtọ_01

Sildenafil Citrate na-agwọ ọrịa erectile 171599-83-0

Nkọwa dị mkpirikpi:

Usoro ọgwụ: C28H38N6O11S

Ibu ibu: 666.70

Nọmba CAS: 171599-83-0

Nọmba EINECS: 200-659-6

Ebe mgbaze: 187-189 ℃

Isi mmiri: 672.4 ℃

Ebe ọkụ: 360.5 ℃

Njupụta: 1.445g/cm3

Ntụgharị ntụgharị: 1.683


Nkọwa ngwaahịa

Mkpado ngwaahịa

Nkọwa ngwaahịa

Aha Sildenafil Citrate
Nọmba CAS 171599-83-0
Usoro ihe omimi C28H38N6O11S
Ibu arọ molekụla 666.70
Nọmba EINECS 200-659-6
Merck 14,8489
Njupụta 1.445g / cm3
Ọnọdụ nchekwa 2-8 Celsius C
Ụdị Ntụ ntụ
Agba Ọcha
Mmiri solubility DMSO:> 20mg/mL

Ụdị okwu

Viagra, Sildenafil citrate; 1-[3- (4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo [4,3-d] pyrimidin-5-yl) -4-ethoxyphenyl] sulfonyl] -4-methylpiperazinecitratesalt; 5-[2-Ethoxy-5- (4-methylpiperazin-1-yl) sulfonylphenyl] -1-methyl-3-propyl-4H-pyrazolo [5,4-e] pyrimidin-7-onecitratesalt; 1-[3- (6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo [4,3-d] pyrimidin-5-yl) -4-ethoxyphenyl] sulfonyl] -4-methylpiperazine,2-hydroxy-1,2,3-propanetricarboxylate; SildenafilCitrate (100mg); Sildenafilcitrate,>=99%;Sildenafilcitrate,Ọkachamara; 5-[2-Ethoxy-5-[(4-methyl-piperazin-1-yl) sulfonyl] phenyl] -1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo [4,3-d] pyrimidin-7-onecitrate

Mmetụta ọgwụ

Ihe omume ọgwụ
Sildenafil citrate bụ 5-phosphodiesterase inhibitor na-ahọrọ nke na-eme ka nitric oxide-based, cyclic gunosine monophosphate-mediated pulmonary vasodilation site na igbochi nkwụsị nke cyclic guanosine monophosphate. Na mgbakwunye na mgbasawanye kpọmkwem nke arịa ọbara pulmonary, ọ nwekwara ike igbochi ma ọ bụ gbanwee nhazigharị vaskụla.

 

Njirimara ọgwụ na ngwa
Sildenafil citrate, aha ahia Viagre, nke a na-akpọkarị Viagra, bụ cyclic guanosine monophosphate (cGMP) -ụdị phosphodiesterase ụdị 5 (PDE5) inhibitor nke nwere ike ịkwalite nrụpụta mgbe nchịkwa ọnụ gasịrị. Sildenafil citrate nwere ike ịkwalite mmetụta nke nitric oxide (NO) site na igbochi ụdị 5 phosphodiesterase nke na-emepụta cyclic guanosine monophosphate (cGMP) na corpus cavernosum. Mee ka ọkwa cGMP dị na corpus cavernosum dị jụụ, mee ka ahụ ike dị nro dị na corpus cavernosum dịkwuo mma, mee ka ọbara na-abanye n'ọbara, gbatịa oge ịgbatị amụ ma mee ka ọ dịkwuo ike. Maka ndị ọrịa na-adịghị ike na-arụ ọrụ erectile. Ndị okenye na-eji ọnụ 50 mg ọnụ oge ọ bụla, ruo otu ugboro n'ụbọchị, ma jiri ya dị ka achọrọ ihe dị ka elekere 1 tupu enwe mmekọahụ. Oke kachasị bụ 0.1g kwa oge.

 

Na vivo ọmụmụ
N'ime nkịta aneshetized, Sildenafil citrate na-eme ka ọrụ penile erectile na-arụ ọrụ n'okpuru mkpali akwara pelvic site na ịlele nrụgide intracavernous. Sildenafil citrate n'ụzọ pụtara ìhè tụgharịrị ezumike carbamoylcholine na-adịghị mma ma gbochie nguzobe superoxide na anụ ahụ cavernosal nke oke bekee hypercholesterolemic. Na oke Sprague-Dawley, Sildenafil na-eme ka arụ ọrụ erectile dịkwuo mma n'ụzọ na-adabere na oge, na mgbake kachasị na-eme na ụbọchị 28 na dose nke 20 mg / kg kwa ụbọchị. Na oke Sprague-Dawley, nchịkwa nke Sildenafil mere ka nchekwa na nchekwa nke collagen muscle dị nro na-echekwa CD31 na eNOS okwu. Na oke Sprague-Dawley, Sildenafil belatara nke ukwuu index apoptotic ma mụbaa phosphorylation nke akt na eNOS ma e jiri ya tụnyere otu njikwa.

 

 


  • Nke gara aga:
  • Osote:

  • Dee ozi gị ebe a ziga anyị ya